Multinational companies have more drugs for PVA
By Lee, Hye-Kyung | translator Choi HeeYoung
21.10.25 12:03:20
°¡³ª´Ù¶ó
0
The total number of negotiations between 5 and 8 consecutive countries in Korea
Rep. Lee Jong-sung said, "There is no overall reverse discrimination, but there must be a motive for the development of new domestic drugs"
The NHIS made an official position that it cannot accept the criticism that new domestic drugs are being reversely discriminated within the PVA.
After the parliamentary audit of the National Assembly's Health and Welfare Committee on the 15th, The NHIS replied, "It cannot be regarded as reverse discrimination in domestic new drugs," when asked about reverse discrimination by People Power Party lawmaker Lee Jong-sung.
For this reason, as a result of analyzing drugs applied more than three times in a row since the reorganization of the PVA system in 2014, seven drugs were included in the case of "Type Ka and Na" and six drugs in the case of "Type Da."
However, among them, only s
Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)